Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Chapter 19 Addiction Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse • National health problem • Actual prevalence of substance abuse difficult to determine • Detrimental effects – Costs to business, industry – Motor vehicle accidents, fatalities – Prenatal drug exposure – Increase in violence Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse (cont.) • Children of alcoholics are four times more likely to develop problems with alcohol. • 50% of all traffic violations involve alcohol. • 20% of suicide victims are alcoholics. • >30% of alcoholic deaths are suicides or related accidents involving alcohol. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Diagnostic Classes of Substance Abuse • Important terms – Intoxication – Withdrawal syndrome – Detoxification – Substance abuse – Substance dependence Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Categories of Drugs • • • • • • • Alcohol Sedatives, hypnotics, and anxiolytics Stimulants Cannabis Opioids Hallucinogens Inhalants Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Clinical Course: Alcoholism • First episode of intoxication → continuing problems with alcohol → first blackout → continued drinking → development of tolerance → tolerance break → continued drinking → functioning becoming affected → periods of abstinence/temporary controlled drinking → escalation of alcohol intake → more problems → subsequent crisis → continuation of cycle Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Etiology • Biologic factors – Genetic vulnerability – Neurochemical influences • Psychological factors – Family dynamics – Coping styles • Social, environmental factors – Culture, social attitudes, peer behaviors – Laws, cost, availability Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Cultural Considerations • Views variable – Muslims: no alcohol – Jewish: wine an integral part of religious rites – Some Native American tribes: peyote (hallucinogen) – Japanese: alcohol not a drug Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Cultural Considerations (cont.) • Genetic traits of certain ethnic groups as predisposing to or protective against alcoholism • Variations in enzymatic activities among Asians, African Americans, whites • Alcohol abuse: a part in the five leading causes of death for Native Americans Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Alcohol • CNS depressant: relaxation/loss of inhibitions • Vomiting, unconsciousness, respiratory depression with overdose (see Box 19.1) Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Alcohol (cont.) • Symptoms of withdrawal – Onset within 4 to 12 hours after cessation or marked reduction of alcohol intake (see Box 19.2); peaking on second day; complete in about 5 days – Benzodiazepines for safe withdrawal Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Is the following statement true or false? • Alcohol is a central nervous system stimulant. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • False • Rationale: Alcohol is classified as a central nervous system depressant. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Sedatives, Hypnotics, and Anxiolytics • CNS depressants – Benzodiazepines alone, with oral overdose rarely fatal; lethargy, confusion – Barbiturate overdose possibly lethal; coma, respiratory arrest, cardiac failure, death • Withdrawal dependent on drug • Detoxification via drug tapering Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Stimulants (Amphetamines, Cocaine) • CNS stimulants • High or euphoric feeling, hyperactivity, hypervigilance; physiologic signs • Seizures, coma with overdose • Onset of withdrawal within hours to several days Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Stimulants (Amphetamines, Cocaine) (cont.) • Withdrawal syndrome: dysphoria, fatigue, vivid and unpleasant dreams, insomnia or hypersomnia, increased appetite, psychomotor retardation or agitation, depressive symptoms, including suicidal ideation for several days • No pharmacologic treatment for withdrawal Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Cannabis (Marijuana) • Used for psychoactive effects • Excessive use possibly leads to delirium or cannabisinduced psychotic disorder • No overdose • No clinically significant withdrawal syndrome – Possible symptoms of insomnia, muscle aches, sweating, anxiety, tremors • Symptomatic treatment Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Opioids • CNS depressants; desensitization; euphoria; well-being • Overdose: coma, respiratory depression, pupil constriction, unconsciousness, death – Naloxone as treatment for overdose Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Opioids (cont.) • Withdrawal: – Short-acting drugs (i.e., heroin): onset in 6 to 24 hours; peaking in 2 to 3 days and gradually subsiding in 5 to 7 days – Longer-acting drugs (i.e., methadone): onset in 2 to 4 days, subsiding in 2 weeks Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Hallucinogens • Reality distortion; symptoms like psychosis (hallucinations [usually visual], depersonalization) • No overdose; occurrence of toxic reactions (primarily psychological) • PCP toxicity: seizures, hypertension, hyperthermia, respiratory depression Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Hallucinogens (cont.) • Supportive treatment • No withdrawal syndrome • Flashbacks possible for few months up to 5 years Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Inhalants • Intoxication: neurologic, behavioral symptoms • Acute toxicity – Anoxia, respiratory depression, vagal stimulation, dysrhythmias – Death possible from bronchospasm, cardiac arrest, suffocation, or aspiration • No withdrawal or detoxification • Supportive treatment Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Is the following statement true or false? • A person who abuses hallucinogens will experience a withdrawal syndrome on cessation of use. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • False • Rationale: There is no withdrawal syndrome associated with hallucinogen use. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse Treatment • Concept: medical illnesses, chronic, progressive, characterized by remissions and relapses • Treatment models: – Hazelden Clinic model – 12-step program of Alcoholics Anonymous (AA; see Box 19.3) Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse Treatment (cont.) • Individual, group counseling • Treatment settings • Pharmacologic treatment: safe withdrawal; prevent relapse (see Table 19.1) Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Dual Diagnosis • Substance abuse + another psychiatric illness Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Dual Diagnosis (cont.) • Successful treatment, relapse prevention strategies (see Nursing Care Plan) – Healthy, nurturing, supportive living environments – Help with fundamental life changes, such as finding job, abstinent friends – Connections with other recovering people – Treatment of comorbid conditions Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse and Nursing Process Application • Assessment – History: chaotic family life, family history, crisis that precipitated treatment – General appearance, motor behavior – Mood, affect: tearful; expressing guilt, remorse; angry; sullen; quiet; unwilling to talk – Thought process, content: denial; blaming others; rationalization Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse and Nursing Process Application (cont.) • Assessment (cont.) – Sensorium, intellectual processes: intact – Judgment, insight: poor judgment; impulsivity; ability to control substance use – Self-concept: low self-esteem; problems with feelings – Roles, relationships: often strained – Physiologic considerations: poor nutrition; sleep disturbances; liver damage; HIV infection; lung damage Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse and Nursing Process Application (cont.) • Data analysis/nursing diagnoses – Related to physical health status – Related to substance use • Outcome identification – Abstain from alcohol and drug use. – Accept responsibility for own behavior. – Practice non–chemical-coping alternatives. – Establish an effective after-care plan. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Is the following statement true or false? • A patient who abuses substances will commonly state that he or she can control his or her use of the substance. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • True • Rationale: Typically, the patient is in denial and commonly states that he or she can stop using the drug anytime. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse and Nursing Process Application (cont.) • Interventions – Health teaching for patient, family (see Client Family Education box) – Addressing family issues (codependence, shifting roles) – Coping skills • Evaluation Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Elder Considerations • Approximately 30% to 60% of elders in treatment began drinking abusively after age 60. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Elder Considerations (cont.) • Risk factors for late-onset substance abuse in elders: – Chronic illness causing pain; long-term use of prescription medications (sedative-hypnotics, anxiolytics); life stress; loss; social isolation; grief; depression; an abundance of discretionary time and money • Physical problems associated with substance abuse develop more quickly. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Community-Based Care • Outpatient treatment • Freestanding substance abuse treatment facilities • Self-help programs (AA, Rational Recovery) • Agency-sponsored aftercare program • Individual or family counseling • Clinic or physician’s office Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Mental Health Promotion • Public awareness, educational advertising • Early identification of older adults with alcoholism • The College Drinking Prevention Program Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Substance Abuse in Health Professionals • Ethical, legal responsibility to report suspicious behavior to supervisor • General warning signs – Poor work performance/frequent absenteeism – Unusual behavior/slurred speech – Isolation from peers • Specific behaviors Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Self-Awareness Issues • Examine own beliefs, family behavior about alcohol and drugs. • Recognize that substance abuse is chronic illness with relapses, remissions. • Remain objective, reasonably optimistic. Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins